Icotrokinra vs Liraglutide

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Icotrokinra is primarily a immune support peptide, while Liraglutide is used for weight management & metabolic.

This page compares Icotrokinra and Liraglutide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

IcotrokinraLiraglutide
CategoryImmune SupportWeight Management & Metabolic
Regulatory status (US)FDA approvedFDA approved
Typical dosage0.6-3.0 mg
Frequencydaily
Reported benefitsWeight loss, blood sugar control, cardiovascular protection
Reported side effectsNausea, GI disturbances, potential pancreatitis

Key differences

Primary use. Icotrokinra is categorised under Immune Support, while Liraglutide falls under Weight Management & Metabolic. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Icotrokinra: FDA-approved. Liraglutide: FDA-approved.

Dosing. Typical dosing for Icotrokinra is not catalogued. Liraglutide is typically dosed at 0.6-3.0 mg (daily).

Can you stack them?

Some protocols combine peptides, but stacking Icotrokinra and Liraglutide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Icotrokinra and Liraglutide?
Icotrokinra is primarily a immune support peptide, while Liraglutide is used for weight management & metabolic. Icotrokinra is FDA-approved for one or more indications, whereas Liraglutide is FDA-approved for one or more indications.
What is Icotrokinra used for?
Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.
What is Liraglutide used for?
FDA-approved GLP-1 for weight loss.
Can you take Icotrokinra and Liraglutide together?
Some users combine peptides within a single protocol, but stacking Icotrokinra and Liraglutide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Icotrokinra or Liraglutide FDA-approved?
Icotrokinra is FDA-approved for one or more indications. Liraglutide is FDA-approved for one or more indications.

Read the full articles

  • Icotrokinra — full monograph: mechanism, research, dosing & references
  • Liraglutide — full monograph: mechanism, research, dosing & references

More Immune Support comparisons

Icotrokinra compared across categories

← All peptide comparisons